Abstract: The present invention relates to an emulsion composition for chemoembolization comprising a nanoparticle comprising a drug and a biocompatible polymer, a water-soluble contrast agent and a water-insoluble contrast agent, and a water-insoluble drug as well as an aqueous drug can be administered in a form of stable emulsion, and drugs are slowly released, thereby enhancing the effect of chemoembolization.

Abstract: The present invention relates to an emulsion composition for chemoembolization comprising a nanoparticle comprising a drug and a biocompatible polymer, a water-soluble contrast agent and a water-insoluble contrast agent, and a water-insoluble drug as well as an aqueous drug can be administered in a form of stable emulsion, and drugs are slowly released, thereby enhancing the effect of chemoembolization.

Abstract: Disclosed are microparticles containing physiologically active peptides, a method for preparing the same, and a pharmaceutical composition comprising the same.

Abstract: Provided are a pharmaceutical composition with improved stability including palonosetron, a preparation method thereof, and a pharmaceutical package including the pharmaceutical composition.

Abstract: Provided are a pharmaceutical composition with improved stability including palonosetron, a preparation method thereof, and a pharmaceutical package including the pharmaceutical composition.

Abstract: The present invention relates to a macromolecule for delivering protein, polypeptide or peptide drugs and to a production method for the same, as well as to a slow release composition for protein, polypeptide or peptide drugs comprising the same, and more specifically relates to a polylactic acid derivative compound of Chemical formula 1 of which the numerical average molecular weight is no more than 7000 daltons and to a production method for the same, as well as to a slow release composition for protein, polypeptide or peptide drugs using the same and to a production method for the same.

Abstract: Provided are a pharmaceutical composition with improved stability including palonosetron, a preparation method thereof, and a pharmaceutical package including the pharmaceutical composition.

Abstract: Disclosed are microparticles containing physiologically active peptides, a method for preparing the same, and a pharmaceutical composition comprising the same.

Abstract: The present invention relates to a macromolecule for delivering protein, polypeptide or peptide drugs and to a production method for the same, as well as to a slow release composition for protein, polypeptide or peptide drugs comprising the same, and more specifically relates to a polylactic acid derivative compound of Chemical formula 1 of which the numerical average molecular weight is no more than 7000 daltons and to a production method for the same, as well as to a slow release composition for protein, polypeptide or peptide drugs using the same and to a production method for the same.

Abstract: Disclosed are microparticles containing physiologically active peptides, a method for preparing the same, and a pharmaceutical composition comprising the same.

Abstract: The present invention relates to an amphiphilic block copolymer of a hydrophilic block and a hydrophobic block with a terminal hydroxyl group wherein the terminal hydroxyl group of the hydrophobic bock is substituted with a tocopherol or cholesterol group. It also relates to polymeric compositions capable of forming stable micelles in an aqueous solution, comprising the amphiphilic block copolymer and a polylactic acid derivative wherein one or more ends of the polylactic acid are covalently bound to at least one carboxyl group.

Abstract: A mobile communication device comprises: a liquid crystal (LC) panel; a drive integrated circuit connected to the LC panel; a keypad printed circuit board (PCB) having a keypad connected to the drive integrated circuit; a flexible printed circuit board (FPCB) for connecting the drive integrated circuit and the keypad PCB to each other; a backlight assembly having an outer case, for supplying light to the LC panel; and a fixing member for fixing the FPCB and one end of the outer case of the backlight assembly by adhering to each other. The mobile communication device prevents a part of light emitted from an optical source from being displayed on a screen with a high brightness.

Abstract: A mobile communication device comprises: a liquid crystal (LC) panel; a drive integrated circuit connected to the LC panel; a keypad printed circuit board (PCB) having a keypad connected to the drive integrated circuit; a flexible printed circuit board (FPCB) for connecting the drive integrated circuit and the keypad PCB to each other; a backlight assembly having an outer case, for supplying light to the LC panel; and a fixing member for fixing the FPCB and one end of the outer case of the backlight assembly by adhering to each other. The mobile communication device prevents a part of light emitted from an optical source from being displayed on a screen with a high brightness.

Abstract: A mobile communication device comprises: a liquid crystal (LC) panel; a drive integrated circuit connected to the LC panel; a keypad printed circuit board (PCB) having a keypad connected to the drive integrated circuit; a flexible printed circuit board (FPCB) for connecting the drive integrated circuit and the keypad PCB to each other; a backlight assembly having an outer case, for supplying light to the LC panel; and a fixing member for fixing the FPCB and one end of the outer case of the backlight assembly by adhering to each other. The mobile communication device prevents a part of light emitted from an optical source from being displayed on a screen with a high brightness.

Abstract: A mobile communication device comprises: a liquid crystal (LC) panel; a drive integrated circuit connected to the LC panel; a keypad printed circuit board (PCB) having a keypad connected to the drive integrated circuit; a flexible printed circuit board (FPCB) for connecting the drive integrated circuit and the keypad PCB to each other; a backlight assembly having an outer case, for supplying light to the LC panel; and a fixing member for fixing the FPCB and one end of the outer case of the backlight assembly by adhering to each other. The mobile communication device prevents a part of light emitted from an optical source from being displayed on a screen with a high brightness.

Abstract: The present invention relates to an amphiphilic block copolymer of a hydrophilic block and a hydrophobic block with a terminal hydroxyl group wherein the terminal hydroxyl group of the hydrophobic bock is substituted with a tocopherol or cholesterol group. It also relates to polymeric compositions capable of forming stable micelles in an aqueous solution, comprising the amphiphilic block copolymer and a polylactic acid derivative wherein one or more ends of the polylactic acid are covalently bound to at least one carboxyl group.

Abstract: The present invention relates to a pharmaceutical composition containing as an active ingredient, itraconazole. More particularly, the present invention relates to the pharmaceutical composition comprising itraconazole, a polylactic acid derivative, and an amphiphilic block copolymer. The polylactic acid derivative may be combined with a metal ion at the carboxylic acid terminal, and the amphiphilic block copolymer forms micelles or nano-particles in an aqueous medium.

Abstract: The present invention relates to an amphiphilic block copolymer of a hydrophilic block and a hydrophobic block with a terminal hydroxyl group wherein the terminal hydroxyl group of the hydrophobic bock is substituted with a tocopherol or cholesterol group. It also relates to polymeric compositions capable of forming stable micelles in an aqueous solution, comprising the amphiphilic block copolymer and a polylactic acid derivative wherein one or more ends of the polylactic acid are covalently bound to at least one carboxyl group.

Abstract: A dual drug containing adhesive transdermal drug delivery system comprising: a support layer, a first drug containing adhesive layer and a second drug containing adhesive layer each of said layers having a proximal and distal surface wherein each layer is positioned adjacent to the other with each layer having its distal surface laminated to said support layer, and a peelable backing layer positioned over and laminated to the proximal surface of said first and second adhesive layers is disclosed.

Abstract: The invention herein relates to a transdermal drug delivery systern for anti-Inflammatory analgesic. agent comprising diclofenac diethylammonium salt, wherein a backing film (1), a matrix layer (2) containing active ingredients, a release liner (3) which is removed before application onto the skin are laminated therein. Mome particularly, the invention herein relates to a transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonum salt, wherein the transdermal penetration and adhesion of the patch to the body are enhanced by means of a matrix layer which comprises a diclofenac diethylammonum salt as active ingredient in addition to acrylic polymer as adhesive constituent, non-ionic surfacant as absorption enhancer, terpene and dissolution assistant, and the volatile and non-volatile constituents of the composition arc separately applied therein for significantly reducing the manufacturing time thereof.